News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
130,274 Results
Type
Article (9022)
Company Profile (6)
Press Release (121246)
Section
Business (40179)
Career Advice (472)
Deals (5795)
Drug Delivery (28)
Drug Development (22899)
Employer Resources (37)
FDA (3792)
Job Trends (3536)
News (73234)
Policy (6103)
Tag
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (623)
Adcomms (5)
Allergies (24)
Alliances (23862)
ALS (20)
Alzheimer's disease (305)
Antibody-drug conjugate (ADC) (46)
Approvals (3818)
Artificial intelligence (79)
Autoimmune disease (4)
Automation (5)
Bankruptcy (49)
Best Places to Work (3274)
BIOSECURE Act (3)
Biosimilars (34)
Biotechnology (5)
Bladder cancer (22)
Brain cancer (7)
Breast cancer (95)
Cancer (675)
Cardiovascular disease (48)
Career advice (398)
Career pathing (7)
CAR-T (42)
Cell therapy (120)
Cervical cancer (5)
Clinical research (19748)
Collaboration (403)
Compensation (15)
Complete response letters (5)
COVID-19 (492)
CRISPR (14)
C-suite (38)
Cystic fibrosis (30)
Data (549)
Denatured (9)
Depression (13)
Diabetes (78)
Diagnostics (1381)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (29)
Drug pricing (27)
Drug shortages (5)
Duchenne muscular dystrophy (18)
Earnings (6207)
Editorial (4)
Employer branding (5)
Employer resources (33)
Events (9695)
Executive appointments (117)
FDA (4106)
Featured Employer (5)
Friedreich's ataxia (2)
Funding (154)
Gene editing (28)
Generative AI (7)
Gene therapy (79)
GLP-1 (177)
Government (734)
Grass and pollen (1)
Guidances (13)
Healthcare (3865)
Huntington's disease (6)
IgA nephropathy (7)
Immunology and inflammation (21)
Indications (12)
Infectious disease (520)
Inflammatory bowel disease (41)
Inflation Reduction Act (2)
Influenza (7)
Intellectual property (31)
Interviews (100)
IPO (1954)
IRA (7)
Job creations (458)
Job search strategy (326)
Kidney cancer (6)
Labor market (4)
Layoffs (59)
Leadership (5)
Legal (1481)
Liver cancer (25)
Lung cancer (112)
Lymphoma (52)
Machine learning (1)
Management (14)
Manufacturing (88)
MASH (22)
Medical device (2784)
Medtech (2786)
Mergers & acquisitions (3958)
Metabolic disorders (205)
Multiple sclerosis (20)
NASH (10)
Neurodegenerative disease (19)
Neuropsychiatric disorders (3)
Neuroscience (440)
NextGen: Class of 2025 (1399)
Non-profit (1030)
Northern California (472)
Obesity (112)
Opinion (37)
Ovarian cancer (23)
Pain (21)
Pancreatic cancer (22)
Parkinson's disease (34)
Partnered (7)
Patents (42)
Patient recruitment (26)
Peanut (17)
People (7625)
Pharmaceutical (4)
Pharmacy benefit managers (3)
Phase I (5787)
Phase II (8775)
Phase III (6542)
Pipeline (206)
Podcasts (17)
Policy (17)
Postmarket research (876)
Preclinical (1353)
Press Release (23)
Prostate cancer (38)
Psychedelics (6)
Radiopharmaceuticals (62)
Rare diseases (98)
Real estate (1032)
Recruiting (16)
Regulatory (4376)
Reports (3)
Research institute (489)
Resumes & cover letters (60)
RNA editing (1)
RSV (8)
Schizophrenia (24)
Series A (43)
Series B (21)
Service/supplier (1)
Sickle cell disease (18)
Southern California (401)
Special edition (1)
Sponsored (5)
Startups (813)
Stomach cancer (5)
Supply chain (23)
The Weekly (8)
United States (4173)
Vaccines (132)
Venture capitalists (11)
Webinars (1)
Weight loss (71)
Women's health (6)
Worklife (5)
Date
Today (51)
Last 7 days (187)
Last 30 days (651)
Last 365 days (7655)
2025 (1330)
2024 (7704)
2023 (8501)
2022 (9295)
2021 (10816)
2020 (11029)
2019 (10275)
2018 (7823)
2017 (7208)
2016 (6538)
2015 (7087)
2014 (5229)
2013 (4353)
2012 (4617)
2011 (4648)
2010 (4673)
Location
Africa (167)
Alabama (17)
Alaska (2)
Arizona (35)
Arkansas (6)
Asia (8392)
Australia (1203)
California (1067)
Canada (357)
China (116)
Colorado (58)
Connecticut (49)
Delaware (46)
Europe (20435)
Florida (146)
Georgia (37)
Idaho (10)
Illinois (141)
India (5)
Indiana (76)
Iowa (2)
Japan (51)
Kansas (21)
Kentucky (5)
Louisiana (1)
Maine (11)
Maryland (133)
Massachusetts (735)
Michigan (51)
Minnesota (55)
Mississippi (2)
Missouri (12)
Montana (3)
Nebraska (8)
Nevada (8)
New Hampshire (10)
New Jersey (382)
New Mexico (5)
New York (346)
North Carolina (170)
North Dakota (1)
Northern California (472)
Ohio (33)
Oklahoma (6)
Oregon (8)
Pennsylvania (250)
Rhode Island (2)
South America (228)
South Carolina (2)
Southern California (401)
Tennessee (11)
Texas (157)
Utah (39)
Virginia (12)
Washington D.C. (12)
Washington State (111)
Wisconsin (8)
130,274 Results for "withings".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Biopharma Deals Start Flowing at JPM25—With One Dwarfing Last Year’s Activity
J.P. Morgan kicked off with a flurry of deals, with Eli Lilly, GSK and Gilead all announcing deals potentially worth more than $1 billion while J&J committed $14.6 billion to buy Intra-Cellular. These moves have reinvigorated sentiment across the biopharma industry.
January 14, 2025
·
3 min read
·
Annalee Armstrong
GLP-1
Evidence Mounts for Potential of GLP-1s in Alzheimer’s Disease
The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk.
December 9, 2024
·
6 min read
·
Heather McKenzie
Business
Medable Announces Partnership with Withings Health Solutions to Integrate Connected Health Devices in Decentralized Clinical Trials
Medable Inc., the leading SaaS platform provider for patient-centered clinical trials, today announced a new partnership with Withings Health Solutions, the business-to-business division of Withings, one of the global leaders in at-home connected health.
July 21, 2022
·
3 min read
Drug Development
Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001With Growing Body of Clinical Evidence, ALX-001 is Ready to Commence Phase 2 Studies
Allyx Therapeutics, a clinical-stage biotechnology company working to deliver a novel approach to preserve and protect synapses for people living with neurodegenerative diseases, announced that the first Alzheimer’s disease patient has been dosed with its lead compound, ALX-001, in a clinical study.
June 11, 2024
·
3 min read
Pharm Country
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
Tevogen Bio Holdings Inc. has entered into a binding term sheet [with an existing investor] to secure up to $50 million of financing.
May 10, 2024
·
6 min read
PreveCeutical Enters into Loan Agreements
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”) announces that it has entered into a series of unsecured, non-convertible and interest-free loan agreements with, the Company’s Chief Executive Officer
June 17, 2024
·
4 min read
Drug Development
Sona’s Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study
Sona’s Chief Medical Officer and the Study’s principal investigator, Dr. Carman Giacomantonio, commented, “With two separate murine cancer models completed, we now believe it is clear that Sona’s THT therapy causes cancer specific proteins (cancer antigens) to become visible to the immune system.
June 26, 2024
·
6 min read
Biotech Bay
Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease
Ultragenyx Pharmaceutical Inc. released its 2023 Corporate Responsibility Report, which showcases the company’s efforts to transform the lives of individuals and families impacted by rare and ultrarare diseases, empower its employees, and make a meaningful impact on the communities it partners with.
April 30, 2024
·
8 min read
Awakn Life Sciences Announces Closing of Tranche of Private Placement - April 2024
Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology company developing medication-assisted treatments for addiction with...
April 17, 2024
·
5 min read
FDA
Amgen Contests J&J’s Stelara with FDA Approval for Interchangeable Biosimilar
Ahead of the Inflation Reduction Act’s drug price negotiations, the regulator has approved Amgen’s biosimilar challenge to Johnson & Johnson’s Stelara—with an interchangeable designation to boot.
November 2, 2023
·
3 min read
·
Tristan Manalac
1 of 13,028
Next
